Non Small Cell Lung Cancer News and Research

RSS
Non-Small Cell Lung Cancers are a group of lung cancers that are named for the kinds of cells found in the cancer and how the cells look under a microscope. The three main types of non-small cell lung cancer are squamous cell carcinoma, large cell carcinoma, and adenocarcinoma. Non-small cell lung cancer is the most common kind of lung cancer.
New combination therapy found to be well tolerated in patients with aggressive brain tumor

New combination therapy found to be well tolerated in patients with aggressive brain tumor

IASLC 2019 Small Cell Lung Cancer Meeting focuses on immunotherapy and patient perspective

IASLC 2019 Small Cell Lung Cancer Meeting focuses on immunotherapy and patient perspective

Queen’s University Belfast and Domainex identify novel first-in-class FLIP inhibitors

Queen’s University Belfast and Domainex identify novel first-in-class FLIP inhibitors

Study provides new pathway for controlling inflammation

Study provides new pathway for controlling inflammation

City of Hope exhibits current studies and data on cancer therapies at AACR

City of Hope exhibits current studies and data on cancer therapies at AACR

Prophylactic cranial irradiation used as standard approach for patients with NSCLC

Prophylactic cranial irradiation used as standard approach for patients with NSCLC

Precision cancer drugs spark powerful immune response and boost effects of immunotherapy

Precision cancer drugs spark powerful immune response and boost effects of immunotherapy

Increased muscle mass could save your life

Increased muscle mass could save your life

New microfluidic device can isolate individual cancer cells from blood samples

New microfluidic device can isolate individual cancer cells from blood samples

New research finds how cancer cells acquire resistance to molecular-targeted drugs

New research finds how cancer cells acquire resistance to molecular-targeted drugs

Harnessing the evolutionary games played by cancer cells to advance therapies

Harnessing the evolutionary games played by cancer cells to advance therapies

Novel approach uses small amounts of tissue to quantify PD-L1 expression levels in tumors

Novel approach uses small amounts of tissue to quantify PD-L1 expression levels in tumors

Trojan Horse approach to cancer therapy shows promise

Trojan Horse approach to cancer therapy shows promise

Drug treating breast cancer may be effective in treating lung and ovarian cancer

Drug treating breast cancer may be effective in treating lung and ovarian cancer

First precision medicine trial in lung cancer expands to include more patients

First precision medicine trial in lung cancer expands to include more patients

QIAGEN receives first companion diagnostic approval in Japan

QIAGEN receives first companion diagnostic approval in Japan

MD Anderson Cancer Center and 4D pharma team up to evaluate live biotherapeutic oncology pipeline

MD Anderson Cancer Center and 4D pharma team up to evaluate live biotherapeutic oncology pipeline

Patients with stage IV disease now living a median 6.8 years after ALK+ NSCLC diagnosis

Patients with stage IV disease now living a median 6.8 years after ALK+ NSCLC diagnosis

CRISPR may restore effectiveness of chemotherapies used to treat lung cancer

CRISPR may restore effectiveness of chemotherapies used to treat lung cancer

International study increases group of lung cancer patients who may benefit from immunotherapy

International study increases group of lung cancer patients who may benefit from immunotherapy